LICA PHARMACEUTICALS ApS: Financial statements 2012
CVR: 25332520
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 468,291 and a net result of DKK 953,184. The profit margin was 203.5%. Equity in the 2012 report amounted to DKK 9,258,126. The solvency ratio was 99.8%.
- Revenue
- DKK 468,291
- Gross Profit
- DKK 295,665
- Profit/Loss
- DKK 953,184
- Equity
- DKK 9,258,126
- Total Assets
- DKK 9,275,673
Official annual report
Keep an eye on LICA PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of September 18, 2012, JUT NR. 2180 A/S has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of May 25, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of LICA PHARMACEUTICALS ApS.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.